Epidemiological characterization and geographic distribution of human immunodeficiency virus/acquired immunodeficiency syndrome infection in North African countries

Figure 1 Selection of studies of human immunodeficiency virus/acquired immunodeficiency syndrome epidemiology in North Africa, 2008-2017, for inclusion in the meta-analysis. HIV: Human immunodeficiency virus.

Figure 2 Prevalence of human immunodeficiency virus/acquired immunodeficiency syndrome in North African countries in 2008 and 2017.

Figure 3 Forest plot of the seroprevalence of human immunodeficiency virus/acquired immunodeficiency syndrome among different populations in Northern Africa 2008-2017. IDUs: Injection drug users; MSM: Men who have sex with men; IVDUs: Intravenous drug users; CI: Confidence interval.

Figure 4 Gender and age-specific distribution of new human immunodeficiency virus/acquired immunodeficiency syndrome patients reported in North African countries from 2008 to 2017. HIV: Human immunodeficiency virus; AIDS: Acquired immunodeficiency syndrome.

Figure 5 The prevalence of human immunodeficiency virus/acquired immunodeficiency syndrome among different population groups within North African countries, including blood donors, nosocomial infection, injection drug users, sexually promiscuous individuals, and others. BD: Blood donors; NS: Nosocomial infection; IDUs: Injection drug users; PC: Promiscuous individuals; OT: Others.

Figure 6 Distribution of human immunodeficiency virus genotypes in North African countries.

Figure 7 Geographic variation of the incidence of human immunodeficiency virus/acquired immunodeficiency syndrome in North African countries from 2008 to 2017.

Figure 8 Spatiotemporal clusters of human immunodeficiency virus/acquired immunodeficiency syndrome in North African countries 2008-2017.